From the Department of Anaesthesiology and Perioperative Medicine, Waitemata District Health Board (MUS, DAR, MTK), Health and Rehabilitation Research Institute, Auckland University of Technology (DAR, PJM), and Faculty of Medical and Health Sciences, University of Auckland (MTK).
Eur J Anaesthesiol. 2019 Feb;36(2):123-129. doi: 10.1097/EJA.0000000000000940.
Early postoperative mobilisation is important for enhanced recovery, but can be hindered by orthostatic intolerance, characterised by dizziness, nausea, vomiting, feeling of heat, blurred vision and ultimately syncope. Although the incidence of orthostatic intolerance following total hip arthroplasty has been identified, few studies have yet investigated potential risk factors for developing orthostatic intolerance after hip arthroplasty.
The aim of this study was to assess the incidence of orthostatic intolerance on the first postoperative day after total hip arthroplasty, potential predisposing risk factors for developing orthostatic intolerance and its effect on length of stay.
A prospective observational study.
Tertiary hospital, Auckland, New Zealand, May to September 2015.
One hundred and seventeen consecutive patients undergoing unilateral total hip arthroplasty. Patients were excluded if they had revision surgery.
Incidence of orthostatic intolerance during mobilisation on the first postoperative day. Significant peri-operative risk factors for developing orthostatic intolerance were identified using logistic regression. Length of stay was compared between orthostatic intolerant and orthostatic tolerant patients using the Mann-Whitney U-test.
On the first postoperative day, 22% of patients failed mobilisation due to orthostatic intolerance. Factors independently associated with orthostatic intolerance were female sex; OR (95% CI), 3.11 (1.01 to 9.57), postoperative use of gabapentin; OR 3.55 (1.24 to 10.15) and high peak pain levels (≥5/10) during mobilisation; OR 4.05 (1.30 to 12.61). Overall, 78% of patients were correctly identified. The model was more accurate at predicting those who would not get orthostatic intolerance (89% correct), compared with those who did have orthostatic intolerance (39% correct). Length of stay was longer in patients with orthostatic intolerance (P = 0.019).
Orthostatic intolerance is common after total hip arthroplasty. Optimising pain control prior to mobilisation and limiting gabapentin use may modify the risk of developing postoperative orthostatic intolerance. Although personalised recovery pathways appear attractive, at present, the ability to predict at-risk individuals is still limited.
早期术后活动对于加速康复非常重要,但可能会受到直立不耐受的阻碍,其特征为头晕、恶心、呕吐、发热感、视力模糊,最终导致晕厥。尽管全髋关节置换术后直立不耐受的发生率已经确定,但很少有研究调查髋关节置换术后发生直立不耐受的潜在危险因素。
本研究旨在评估全髋关节置换术后第一天发生直立不耐受的发生率、发生直立不耐受的潜在易感危险因素及其对住院时间的影响。
前瞻性观察研究。
新西兰奥克兰的一家三级医院,2015 年 5 月至 9 月。
连续 117 例接受单侧全髋关节置换术的患者。如果患者接受翻修手术,则将其排除在外。
术后第一天活动时发生直立不耐受的发生率。使用逻辑回归识别发生直立不耐受的显著围手术期危险因素。使用 Mann-Whitney U 检验比较直立不耐受和直立耐受患者的住院时间。
术后第一天,有 22%的患者因直立不耐受而无法活动。与直立不耐受独立相关的因素为女性;比值比(95%可信区间)为 3.11(1.01 至 9.57)、术后使用加巴喷丁;比值比为 3.55(1.24 至 10.15)和活动时疼痛高峰水平较高(≥5/10);比值比为 4.05(1.30 至 12.61)。总体而言,有 78%的患者预测正确。该模型在预测不会发生直立不耐受的患者方面更准确(89%正确),而在预测确实发生直立不耐受的患者方面准确性较差(39%正确)。直立不耐受患者的住院时间更长(P = 0.019)。
全髋关节置换术后直立不耐受很常见。在活动前优化疼痛控制并限制加巴喷丁的使用可能会改变术后直立不耐受的风险。尽管个性化康复途径似乎很有吸引力,但目前预测高危人群的能力仍然有限。